Continuous Manufacturing in Solid-Dosage Drug Production, an Interview with Doug Hausner, C-SOPS

Article

An interview with Doug Hausner, C-SOPS, about continuous manufacturing

Continuous manufacturing offers the potential for improved quality, higher production efficiency, and smaller, more flexible equipment. Doug Hausner, Associate Director for the Engineering Research Center for Structured Organic Particulate Systems (C-SOPS) based at Rutgers University in New Jersey, USA, speaks with Pharmaceutical Technology about the current and future use of continuous processes in solid-dosage drug production.

Recent Videos
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Pharm Tech Group looks at the challenges surrounding the development and manufacture of ATMPs in more detail with Agne Vaitkeviciene, CEO of Memel Biotech.
Pharm Tech Group sits down with Bernard Sagaert, CEO of etherna, to examine the role of mRNA in the treatment of autoimmune diseases.
Related Content